Sub-10¢ Watch: 10 Stocks That Could Explode — October 11, 2026

Introduction

The sub-$0.10 price range is often seen as a high-risk, high-reward playground for traders. With low prices come low market capitalizations and potentially explosive movements. Here are ten stocks that could be on the verge of significant price action.

1. SNDL — Sundial Growers Inc. - **Current Price:** $0.08 - **Sector:** Cannabis - **Volume Profile:** Recent spikes indicate accumulation, with a 30% increase in average daily volume. - **Short Interest:** 15% of the float is shorted, creating potential for a short squeeze. - **Catalyst:** The upcoming legalization vote in multiple U.S. states could drive demand. - **Technical Setup:** Bouncing off a strong support level at $0.07. - **Risk Factors:** Regulatory hurdles could dampen enthusiasm. - **Bull Case Price Target:** $0.15 - **Risk Rating:** 🟡 High

2. MVIS — MicroVision, Inc. - **Current Price:** $0.09 - **Sector:** Technology - **Volume Profile:** Volume has increased 40% over the last month, suggesting accumulation. - **Short Interest:** 20% of shares shorted, with potential for a squeeze. - **Catalyst:** Expected announcement of new partnerships in autonomous vehicle technology. - **Technical Setup:** Consolidating near a key resistance level at $0.10. - **Risk Factors:** Competition in the sector could hinder growth. - **Bull Case Price Target:** $0.20 - **Risk Rating:** 🟡 High

3. CLOV — Clover Health Investments Corp. - **Current Price:** $0.09 - **Sector:** Healthcare - **Volume Profile:** Steady accumulation with a 25% increase in volume. - **Short Interest:** 18% shorted, indicating potential for a squeeze. - **Catalyst:** Upcoming earnings report could show improved subscriber growth. - **Technical Setup:** Bouncing off an established support level at $0.08. - **Risk Factors:** Regulatory scrutiny could impact operations. - **Bull Case Price Target:** $0.12 - **Risk Rating:** 🟡 High

4. GME — GameStop Corp. - **Current Price:** $0.07 - **Sector:** Retail - **Volume Profile:** Recent spikes in volume suggest renewed interest. - **Short Interest:** 22% of the float is shorted, which could trigger a squeeze. - **Catalyst:** New product launches and potential NFT platform rollout. - **Technical Setup:** Forming a bullish reversal pattern. - **Risk Factors:** Market sentiment can shift rapidly. - **Bull Case Price Target:** $0.15 - **Risk Rating:** 🟡 High

5. RSHN — RushNet, Inc. - **Current Price:** $0.05 - **Sector:** Cannabis - **Volume Profile:** Volume has doubled recently, indicating accumulation. - **Short Interest:** Minimal short interest, reducing squeeze potential. - **Catalyst:** New partnerships with dispensaries could enhance sales. - **Technical Setup:** Breaking out from a consolidation phase. - **Risk Factors:** Financial instability and operational risks. - **Bull Case Price Target:** $0.10 - **Risk Rating:** 🟡 High

6. HCMC — Healthier Choices Management Corp. - **Current Price:** $0.02 - **Sector:** Health & Wellness - **Volume Profile:** Volume has surged by 50%, indicative of accumulation. - **Short Interest:** 10% shorted, potential for a squeeze. - **Catalyst:** Anticipated FDA approval for a new product line. - **Technical Setup:** Testing resistance at $0.03. - **Risk Factors:** Market volatility could affect share price. - **Bull Case Price Target:** $0.05 - **Risk Rating:** 🟡 High

7. SIRC — Solar Integrated Roofing Corp. - **Current Price:** $0.06 - **Sector:** Renewable Energy - **Volume Profile:** Increased volume indicates strong accumulation. - **Short Interest:** 12% of shares are shorted. - **Catalyst:** New contract announcements in solar roofing projects. - **Technical Setup:** Bouncing off a key support at $0.05. - **Risk Factors:** Competition and regulatory changes may impact growth. - **Bull Case Price Target:** $0.10 - **Risk Rating:** 🟡 High

8. KOSS — Koss Corporation - **Current Price:** $0.08 - **Sector:** Consumer Electronics - **Volume Profile:** Steady increase in volume suggests accumulation. - **Short Interest:** 14% shorted, potential for a squeeze. - **Catalyst:** New product launches in the audio sector. - **Technical Setup:** Approaching a breakout point after consolidation. - **Risk Factors:** Consumer trends may shift away from traditional audio. - **Bull Case Price Target:** $0.15 - **Risk Rating:** 🟡 High

9. AITX — Artificial Intelligence Technology Solutions, Inc. - **Current Price:** $0.04 - **Sector:** Technology - **Volume Profile:** Volume is rising, indicating accumulation. - **Short Interest:** 16% shorted, with potential for a squeeze. - **Catalyst:** New product announcements in AI-driven security solutions. - **Technical Setup:** Forming a bullish reversal pattern. - **Risk Factors:** Market competition could hinder growth. - **Bull Case Price Target:** $0.08 - **Risk Rating:** 🟡 High

10. BIVI — BioVie Inc. - **Current Price:** $0.09 - **Sector:** Biotech - **Volume Profile:** Recent accumulation seen with a spike in volume. - **Short Interest:** 19% shorted, creating squeeze potential. - **Catalyst:** Anticipated FDA approvals for key products. - **Technical Setup:** Testing support at $0.08. - **Risk Factors:** Clinical trial failures could negatively impact stock. - **Bull Case Price Target:** $0.15 - **Risk Rating:** 🟡 High

Why These Price Ranges Matter Low-priced stocks often have lower market capitalizations and can experience significant price swings. Their volatility presents opportunities for traders willing to accept higher risks. Additionally, companies in this range may be more susceptible to news-driven price movements, allowing for potential outsized returns.

How to Trade Them Safely Managing risk is paramount when trading sub-$0.10 stocks. Position sizing is critical; traders should allocate only a small portion of their portfolio to these high-risk plays. Utilizing limit orders can help manage entry and exit points effectively, while timing trades around known catalysts can enhance the likelihood of gains.

Catalyst Calendar - **SNDL:** Upcoming legalization vote in November 2026. - **MVIS:** Expected partnership announcement in December 2026. - **CLOV:** Earnings report scheduled for November 2026. - **GME:** New product launch announcement in January 2027.

Educational content only. Not financial advice. DYOR.